Angene Chemical
Draw
|
Currency :
Home Products

AG008RY9

119-04-0 | Neomycin B

Chemical structure of Neomycin B, CAS 119-04-0
AG008RY9
sdsSDS
sdsCOA

Price

$0.00

Add to Cart
WARNING This product is not for human or veterinary use.
Request For Quotation
CAS Number 119-04-0
Catalog Number AG008RY9(AGN-PC-0PCSGD)
Chemical Name Neomycin B
IUPAC Name (2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-4-[(2R,3R,4R,5S,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol
InChI InChI=1S/C23H46N6O13/c24-2-7-13(32)15(34)10(28)21(37-7)40-18-6(27)1-5(26)12(31)20(18)42-23-17(36)19(9(4-30)39-23)41-22-11(29)16(35)14(33)8(3-25)38-22/h5-23,30-36H,1-4,24-29H2/t5-,6+,7-,8+,9-,10-,11-,12+,13-,14-,15-,16-,17-,18-,19-,20-,21-,22-,23+/m1/s1
InChI Key PGBHMTALBVVCIT-VCIWKGPPSA-N
MDL Number MFCD09788228
Molecular Formula C23H46N6O13
Molecular Weight 614.6437
SMILES N[C@@H]1[C@H]([C@@H]([C@@H](O[C@@H]1O[C@@H]1[C@H](O[C@H]([C@@H]1O)O[C@H]1[C@@H]([C@H](C[C@H]([C@@H]1O)N)N)O[C@H]1O[C@@H]([C@H]([C@@H]([C@H]1N)O)O)CN)CO)CN)O)O
UNII 4BOC774388
Synonyms
Antibiotic 10676, Framycetin, Framycetin Sulfate, Neomycin B, Neomycin B Sulfate, Soframycin, Sulfate, Framycetin, Sulfate, Neomycin B, neomycin, Framycetin, NEOMYCIN B, Soframycin, Actiline, Fradiomycin, Mycifradin, Framicetina, Framycetine, Framycetinum, Soframycine, Neomas, Antibiotique, Fradiomycinum, Actilin, Enterfram, Framygen, Myacyne, Neolate, Nivemycin, Caswell No. 595, Vonamycin powder V, Neomcin, Neomin, Neomycin B sulfate, Fradiomycin B, Neo-Rx, Neomicina [DCIT], Framycetinum [INN-Latin], Neobrettin, PIMAVECORT, Neo-Fradin, 119-04-0, Neomycine [INN-French], Neomycinum [INN-Latin], Framycetine [INN-French], Framicetina [INN-Spanish], USAF CB-19, Framycetin [INN:BAN:DCF], NEOMYCIN SULFATE, CCRIS 5462, HSDB 3242, Neomycine, UNII-4BOC774388, Framycetin sulfate, 1404-04-2, EINECS 204-292-2, EINECS 215-766-3, EPA Pesticide Chemical Code 006303, BRN 0101621, CHEBI:7508, Neomycin solution, PGBHMTALBVVCIT-VCIWKGPPSA-N, C23H46N6O13, Endomixin, Fraquinol, Myacine, 4BOC774388, (1R,2R,3S,4R,6S)-4,6-diamino-2-{[3-O-(2,6-diamino-2,6-dideoxy-beta-L-idopyranosyl)-beta-D-ribofuranosyl]oxy}-3-hydroxycyclohexyl 2,6-diamino-2,6-dideoxy-alpha-D-glucopyranoside, Antibiotic produced by Streptomyces decaris. Neomycin B, Neomicina, Neomycin sulphate, Neomycinum, (2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-4-[(2R,3R,4R,5S,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol, D-Streptamine, O-2,6-diamino-2,6-dideoxy-alpha-D-glucopyranosyl-(1-4)-O-(O-2,6-diamino-2,6-dideoxy-beta-L-idopyranosyl-(1-3)-beta-D-ribofuranosyl-(1-5))-2-deoxy-, NMY, Antibiotic 10676, Tuttomycin, Bycomycin, Jernadex, NEOMYCINB, Framycetin (INN), Soframycin Ophthalmic, VONAMYCIN, Neomycin [INN:BAN], Mycerin, Antibiotic 956, Neomycin trisulfate salt hydrate, (2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-4-[(2R,3R,4R,5S,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxy-tetrahydropyran-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]oxy-3-hydroxy-cyclohexoxy]tetrahyd, (2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-4-[(2R,3R,4R,5S,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxy-tetrahydropyran-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]oxy-3-hydroxy-cyclohexoxy]tetrahydropyran-3,4-diol, AC1L1QVH, Prestwick3_000158, KDR Kinase Inhibitor, 3, BDBM19, SCHEMBL3279, BDG-(1-4)CYY-(5-1)RIB-(3-1)IDG, BDG-(1-4)NEB-(5-1)RIB-(3-1)NED, BSPBio_000296, GTPL709, 4-18-00-07476 (Beilstein Handbook Reference), BPBio1_000326, CHEMBL184618, DTXSID2023359, HMS2089P15, C25H50N6O13, ZINC71928291, AKOS024284361, AN-5730, CS-6390, DB00452, NCGC00179612-01, AN-49153, D-Streptamine, O-2,6-diamino-2,6-dideoxy-.beta.-L-idopyranosyl-(1.->3)-O-.beta.-D-ribofuranosyl-(1->5)]-O-[2,6-diamino-2,6-dideoxy-.alpha.-D-glucopyranosyl-(1->4)]-2-deoxy, HY-17624, LS-96091, LS-96095, SC-83646, ST075177, AB00443887, C01737, D05140, 30384-EP2272825A2, 30384-EP2272838A1, 30384-EP2277898A2, 30384-EP2287165A2, 30384-EP2287166A2, 30384-EP2292620A2, 30384-EP2295401A2, 30384-EP2295402A2, 30384-EP2298776A1, 30384-EP2305662A1, 30384-EP2305695A2, 30384-EP2305696A2, 30384-EP2305697A2, 30384-EP2305698A2, 30384-EP2311464A1, AB00443887-03, MYCIFRADIN; NEOMAS; PIMAVECORT; VONAMYCIN, J-004060, BRD-K71013094-065-01-2, UNII-I16QD7X297 component PGBHMTALBVVCIT-VCIWKGPPSA-N, (2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-{[(1R,2R,3S,4R,6S)-4,6-diamino-2-{[(2S,3R,4S,5R)-4-{[(2R,3R,4R,5S,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy}-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-3-hydroxycyclohexyl]oxy}oxane-3,4-diol, (2S,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-{[(2R,3S,4R,5S)-5-{[(1R,2R,3S,5R,6S)-3,5-diamino-2-{[(2R,3R,4R,5S,6R)-3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy}-6-hydroxycyclohexyl]oxy}-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]oxy}oxane-3,4-diol, 11004-65-2, 6-(2-{(4S,2R,3R,5R)-4-[(5S,6S,2R,3R,4R)-3-amino-6-(aminomethyl)-4,5-dihydroxy( 2H-3,4,5,6-tetrahydropyran-2-yloxy)]-3-hydroxy-5-(hydroxymethyl)oxolan-2-yloxy }(3S,6S,1R,2R,4R)-4,6-diamino-3-hydroxycyc, 6-(2-{(4S,2R,3R,5R)-4-[(5S,6S,2R,3R,4R)-3-amino-6-(aminomethyl)-4,5-dihydroxy( 2H-3,4,5,6-tetrahydropyran-2-yloxy)]-3-hydroxy-5-(hydroxymethyl)oxolan-2-yloxy }(3S,6S,1R,2R,4R)-4,6-diamino-3-hydroxycyclohexyloxy)(3S,2R,4R,5R,6R)-5-amino- 2-(aminomethyl)-2H, lohexyloxy)(3S,2R,4R,5R,6R)-5-amino- 2-(aminomethyl)-2H-3,4,5,6-tetrahydropyran-3,4-diol, Neobiotic, Myciguent, Fradiomycin sulfate, Neomycin A, Cortisporin, Lanabiotic, Mycitracin, Neodecadron, Bykomycin, Dexacidin, Maxitrol, Negamicin, Neofracin, Neomycane, Neosporin, Neosulf, Otocort, Statrol, Biosol, Neamin, Neomix, Lidamycin creme, Neo-medrol, Mycifradin-N, Nebramycin X, Dekamycin V, Neo-Polycin, Neo-Synalar, Streptothricin B, Neo-Cortef, Cordran-N, Neo-mantle creme, Poly-Pred, Neomycin palmitate, Neo-Cort-Dome, Neo-Delta-Cortef, Coly-Mycin S, Mycifradin (TN), Neomycin (ACN, Soframycin (TN), Neomycin [INN], Neo-fradin (TN), Sulfate, Framycetin, Sofra-Tulle (TN), DEXASPORIN, OTICAIR, OTOBIONE, PEDIOTIC, Sulfate, Neomycin B, NEO-HYDELTRASOL, COR-OTICIN, Neo-Tab (TN), MYTREX A, NEO-OTOSOL-HC, NEO-MEDROL ACETATE, D05JNI, D0RD0N, UNII-I16QD7X297, Framycetin [BAN:DCF:INN], NEOSPORIN G.U. IRRIGANT, CID8378, I16QD7X297, BACITRACIN-NEOMYCIN-POLYMYXIN, NSC47151, NEOMYCIN AND POLYMYXIN B SULFATES, NSC156885, C23-H46-N6-O13, P529, NEOMYCIN SULFATE-TRIAMCINOLONE ACETONIDE, D005601, D009355, NEOMYCIN SULFATE-DEXAMETHASONE SODIUM PHOSPHATE, NEOMYCIN AND POLYMYXIN B SULFATES AND GRAMICIDIN, BACITRACIN ZINC-NEOMYCIN SULFATE-POLYMYXIN B SULFATE, NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE, NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE, NEOMYCIN SULFATE AND DEXAMETHASONE SODIUM PHOSPHATE, NEOMYCIN SULFATE AND POLYMYXIN B SULFATE GRAMICIDIN, NEOMYCIN SULFATE-POLYMYXIN B SULFATE-HYDROCORTISONE, BACITRACIN-NEOMYCIN-POLYMYXIN W/ HYDROCORTISONE ACETATE, NEOMYCIN AND POLYMYXIN B SULFATES AND BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE & HYDROCORTISONE, NEOMYCIN & POLYMYXIN B SULFATES & BACITRACIN ZINC & HYDROCORTISONE, NEOMYCIN AND POLYMYXIN B SULFATES, BACITRACIN ZINC AND HYDROCORTISONE, ZINC BACITRACIN,NEOMYCIN SULFATE,POLYMYXIN B SULFATE & HYDROCORTISONE, D-Streptamine, O-2,6-diamino-2,6-dideoxy-.alpha.-D-glucopyranosyl-(1.fwdarw.4)-O-[O-2,6-diamino-2,6-dideoxy-.beta.-L-idopyranosyl-(1.fwdarw.3)-.beta.-D-ribofuranosyl-(1.fwdarw.5)]-2-deoxy-, D-Streptamine, O-2,6-diamino-2,6-dideoxy-.beta.-L-idopyranosyl-(1?3)-O-.beta.-D-ribofuranosyl-(1?5)-O-[2,6-diamino-2,6-dideoxy-.alpha.-D-glucopyranosyl-(1?4)]-2-deoxy-, FRM,

Related Research Chemicals

    CERTIFICATE OF ANALYSIS
    Chemical Name: Batch Number:
    Chemical Structure: CAS Registry No:
    		Product ID:
    Manufacture Date:
    Storage Temperature:
    Formula:
    Molecular Weight:
    Quantity:
    Analysis Data:
    Test: Result:
    Conclusion: The above product meets the specifications of Angene.
    Analyst:Chase
    Date:
    Reviewed by:Jessie
    Date:
    Angene International Limited